Cargando…
Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
BACKGROUND: The heregulin-1ß/HER3-driven pathway is implicated in several epithelial malignancies and its blockade is currently undergoing clinical investigation. Paradoxically, the status and the regulation of this pathway is poorly known in hepatocellular carcinoma (HCC). METHODS: Using 85 HCC obt...
Autores principales: | Buta, Corina, Benabou, Eva, Lequoy, Marie, Régnault, Hélène, Wendum, Dominique, Meratbene, Fatiha, Chettouh, Hamza, Aoudjehane, Lynda, Conti, Filomena, Chrétien, Yves, Scatton, Olivier, Rosmorduc, Olivier, Praz, Françoise, Fartoux, Laetitia, Desbois-Mouthon, Christèle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982118/ https://www.ncbi.nlm.nih.gov/pubmed/27514687 http://dx.doi.org/10.1186/s13046-016-0402-3 |
Ejemplares similares
-
Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
por: Buta, Corina, et al.
Publicado: (2016) -
Ex-Vivo Pharmacological Defatting of the Liver: A Review
por: Goumard, Claire, et al.
Publicado: (2021) -
Regulation of the EGFR/ErbB signalling by clathrin in response to various ligands in hepatocellular carcinoma cell lines
por: Liu, Yuanhui, et al.
Publicado: (2020) -
Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis
por: Aoudjehane, Lynda, et al.
Publicado: (2020) -
Cold-Atmospheric Plasma Induces Tumor Cell Death in Preclinical In Vivo and In Vitro Models of Human Cholangiocarcinoma
por: Vaquero, Javier, et al.
Publicado: (2020)